European stocks fall as Omicron worries rattle investors



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* STOXX 600 gives back a chunk of Wednesdays gains

* Apple suppliers hit by report on slowing demand

* Vifor Pharma surges on takeover speculation (Updates to close)

By Anisha Sircar and Susan Mathew

Dec 2 (Reuters) - European shares fell more than 1% on Thursday, as countries ramped up restrictions to curb the spread of the Omicron coronavirus variant, raising worries about hits to a nascent economic recovery.

The continent-wide STOXX 600 .STOXX closed down 1.2%, giving back more than half of the previous day's gains when a recovery in the pandemic-exposed sectors triggered the STOXX 600's best session in almost six months.

Germany agreed on new COVID-19 restrictions on Thursday that focussed on the unvaccinated, and the United States tightened travel restrictions, while U.S. Treasury Secretary Janet Yellen said the Omicron variant showed the pandemic could be around for "some time."

Travel and leisure shares .SXTP , which suffer the most from movement curbs, fell 2.6%, bringing losses this year to 7%, significantly underperforming other major sectors which are on course to gain in double digits.

Europe's equity benchmark has seen sharp fluctuations in recent days on uncertainties about how contagious and severe the new variant is, and the effectiveness of current vaccines in tackling it.

"We're going to stay in this pattern of up one day and down the next as long as the Omicron story remains an unknown," said David Madden, market analyst at Equiti Capital.

"We won't be re-testing Europe's November highs until we're certain about the variant's knock-on effects, and until we know for sure whether we're going down the road of lockdowns."

The STOXX 600 is now about 5% away from record highs hit mid-November.

Tech stocks .SX8P were the biggest decliners in Europe, with semiconductor companies Infineon Technologies IFXGn.DE , AMS AMS.S and ASML ASML.AS down between 4.4% and 5.7% on a report that Apple Inc AAPL.O warned of slowing demand for its iPhone 13.

Luxury goods firms Hermes HRMS.PA and Richemont CFR.S fell 3.1% and 2.1%, respectively, despite their inclusion in the blue-chip Euro STOXX 50 index .STOXX50E .

"We expect buybacks (in Europe) to catch up in 2022, rising 30%. Consumer, luxury and mining stocks should be prominent buyers of their own shares," Citigroup analysts said in a note.

Vifor Pharma VIFN.S surged 21.0% to the top of Swiss mid-cap index .SMIM after media reports that Australian biotech firm CSL CSL.AX is in talks to buy the drugmaker.

Also capping losses were oil majors BP BP.L , Royal Dutch Shell RDSa.L and TotalEnergies TOTF.PA rising between 0.6% and 1.8% as crude futures rise. London's energy-heavy FTSE 100 .FTSE lost the least among regional peers, closing down 0.6%.
Reporting by Anisha Sircar in Bengaluru; Editing by Shinjini Ganguli and Richard Chang

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.